Objectives: A decline of systemic blood pressure is one of the most common complications during percutaneous coronary intervention (PCI). Urgent elimination of fundamental cause as well as improvement of hemodynamic crisis should be simultaneously accomplished to prevent important organs from severe ischemic damage. Therefore, in this study, we sought to optimize high-risk patients against potential deterioration of hemodynamic status. Methods: Total of 316 consecutive patients underwent PCI in a single cardiovascular center from January 2010 till May 2011 was finally analyzed. They were divided into two groups due to the use of intravenous norepinephrine for hemodynamic support during PCI, and parameters such as patient backgrounds, lesion characteristics and PCI procedures were compared between the groups. Results: The norepinephrine group showed significantly higher age (73 vs 70 years old, p=0.036), higher value of low density lipoprotein cholesterol [116 (93–135) vs 99 (80–125) mg/dl, p<0.01], higher rate of acute coronary syndrome (44 vs 27%, p<0.01) and right coronary artery intervention (49 vs 31%, p<0.01) rather than the non-norepinephrine group. In terms of angiographic and procedural parameters, significantly larger size of deployed stents (3.4 vs 3.1 mm, p<0.01), higher volume of contrast use (221 vs 193 ml, p<0.01), and higher rate of IABP (8.0 vs 1.0%, p<0.01) and intracoronary nicorandil injection (18 vs 4.0%, p<0.01) were observed in the norepinephrine group. In addition, 79% of norepinephrine cases needed multiple injections to stabilize systemic status. Conclusions: The present study demonstrated several preoperative predictors and procedural features of hemodynamic destabilization during PCI. These results may help staffs in the cath lab to correspond to emergent situations quickly and properly.
View full abstract